A Formula to Estimate the Optimal Dosage of Ribavirin for the Treatment of Chronic Hepatitis C: Influence of ITPA Polymorphisms

Antiviral Therapy - United Kingdom
doi 10.3851/imp2251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Influence of HMG-CoA Reductase Inhibitor to Virological Response of Peginterferon/Ribavirin Combination Therapy in Chronic Hepatitis C

Acta Hepatologica Japonica
Hepatology
2008English

Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C

Internal Medicine
Internal MedicineMedicine
2007English

Gender Influence on Treatment of Chronic Hepatitis C Genotype 1

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2010English

Influence of Different Regimens of Direct Acting Antiviral Agents (DAAS) With or Without Ribavirin Used for Chronic Hepatitis C Treatment on the Cardiac Muscles in Egypt

The Journal of Medical Research
2018English

Editorial: Is Ribavirin Needed in the Treatment of Post-Transplant Hepatitis C Recurrence?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Re-Treatment With Interferon Plus Ribavirin of Chronic Hepatitis C Nonresponders to Interferon Monotherapy: A Meta-Analysis of Individual Patient Data

Digestive and Liver Disease
HepatologyGastroenterology
2001English

Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.

Gut
Gastroenterology
1993English

Mechanisms of Action of Interferon and Ribavirin in Chronic Hepatitis C: Summary of a Workshop

Hepatology
MedicineHepatology
2007English

Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy